
|Articles|November 13, 2008
Dr. Zoe Diana Draelos joins Histogen’s scientific advisory board
San Diego - Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports.
Advertisement
San Diego
- Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports.
Dr. Draelos, president of Dermatology Consulting Services, will aid the company in clinical evaluations and product launches in the cosmetic arena.
Histogen is a regenerative medicine company developing products through newborn fibroblasts. Histogen Aesthetics focuses on the development of skin and haircare products for the dermatology, plastic surgery and cosmetics industries.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Oral Minoxidil's Steady-State Release Avoids Cardiotoxic Peaks
5











